Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Indolent Non-Hodgkin's Lymphoma
×
obinutuzumab
×
Clear all
Filters
3
NCT01889797
2017-05-05
PrE0401
PrECOG, LLC.
Phase 2
Terminated
32 enrolled
14 charts